血红蛋白水平与乳腺癌发病风险的关联性研究综述

黄 闪闪, 候 圣祥, 李 星月, 张 俊生, 沈国 双*
青海大学附属医院

摘要


本文综述了血红蛋白水平与乳腺癌发病风险之间的关系。研究表明，血红蛋白及其相关血液学参数在乳腺
癌中具有重要的预后意义。血红蛋白水平低与乳腺癌的晚期相关，且贫血与乳腺癌风险增加有关。血红蛋白成分铁
的作用可能与乳腺癌风险增加有关，这可能是由于氧化应激和雌激素相互作用。本文还探讨了血红蛋白水平影响乳
腺癌发病风险的可能机制，包括血红蛋白和雌激素水平之间的关系、血红蛋白和免疫系统对乳腺癌的影响以及血红
蛋白与乳腺癌的其他机制。最后，本文提出了未来的研究方向和策略，包括开展机制研究、流行病学研究、生物标
志物开发、干预研究和个性化医疗。通过这些研究，我们有望为乳腺癌患者提供更有效的治疗选择，改善他们的预
后和生活质量。

关键词


血红蛋白；乳腺癌；综述；发病风险

全文:

PDF


参考


[1]Newman L.Oncologic anthropology: Global

variations in breast cancer risk, biology, and outcome[J].

Journal of Surgical Oncology,2023, 128: 959-966.

[2]Sedeta E, Jobre B Y, Avezbakiyev B.Breast cancer:

Global patterns of incidence, mortality, and trends[J].Journal

of Clinical Oncology,2023, 41 (16_suppl): 10528-10528.

[3]Xu Y, Wang Y, Yang Y, et al.Global trends and

forecasts of breast cancer incidence and deaths[J].Scientific

Data, 2023, 10 (1).

[4]The Epidemiology of Breast Cancer: Exon

Publications eBooks,2022: 1-20.

[5]Roheel A, Khan A, Anwar F, et al.Global

epidemiology of breast cancer based on risk factors: a

systematic review[J].Frontiers in Oncology,2023.

[6]Epidemiology and Risk Factors of Breast Cancer,

2022: 3-29.

[7]Sha R, Kong X-M, Li X, et al.Global burden of

breast cancer and attributable risk factors in 204 countries and

territories, from 1990 to 2021: results from the Global Burden

of Disease Study 2021[J].Biomarker research,2024, 12 (1).

[8]Chen H J C, Hu S-X, Tu C W.Multiple Oxidative

Modifications on Hemoglobin are Elevated in Breast Cancer

Patients as Measured by Nanoflow Liquid ChromatographyTandem Mass Spectrometry[J].Journal of Pharmaceutical and

Biomedical Analysis,2024, 252: 116477-116477.

[9]Ponzetti M, Capulli M, Angelucci A, et al.Nonconventional role of haemoglobin beta in breast malignancy[J].

British Journal of Cancer,2017, 117 (7): 994-1006.

[10]Chang V C, Chang V C, Cotterchio M, et al.Iron

intake, body iron status, and risk of breast cancer: a systematic

review and meta-analysis[J].BMC Cancer,2019, 19 (1): 543-543.

[11]Thompson H J, Neil E S, Mcginley J N.Pre-Clinical

Insights into the Iron and Breast Cancer Hypothesis[J].

Biomedicines,2021, 9 (11): 1652-.

[12]Vaupel P, Mayer A, Höckel M.Impact of hemoglobin

levels on tumor oxygenation: the higher, the better?[J].

Strahlentherapie Und Onkologie,2006, 182 (2): 63-71.

[13]Janni W, Strobl B, Rack B, et al.Der Einfluss des

Hämoglobinwertes auf die hämatogene Tumorzelldisseminierung

zum Zeitpunkt der Primärdiagnose des Mammakarzinoms[J].

Deutsche Medizinische Wochenschrift, 2002, 127 (3): 71-77.

[14]Moore A, Shannon J, Chen C, et al.Dietary and

stored iron as predictors of breast cancer risk: A nested casecontrol study in Shanghai[J].International Journal of Cancer,

2009, 125 (5): 1110-1117.

[15]Rakha E A, Tse G, Quinn C.An update on the

pathological classification of breast cancer[J].Histopathology,

2022, 82 (1): 5-16.

[16]Das D.Breast Cancer Classification: A Review[J].

International Journal of Health Sciences and Research,2022,

12 (10): 140-149.

[17]Subtypes of Breast Cancer: Exon Publications

eBooks, 2022: 31-42.[18]Mir M A: Introduction to Breast Cancer,2023: 1-22.

[19]Roy M, Fowler A M, Ulaner G A, et al.Molecular

Classification of Breast Cancer[J].Pet Clinics,2023.

[20]Hayum A A, Jaya J, Sivakumar R, et al. Critical

Review on Breast Cancer Classification[C],2022: 1-6.

[21]Smolarz B, Nowak A Z, Romanowicz H.Breast

Cancer— Epidemiology, Classification, Pathogenesis and

Treatment (Review of Literature)[J].Cancers,2022, 14 (10):

2569-2569.

[22]Chan P F, Hamid R A.An overview of breast

cancer: Classification and related signaling pathways[J], 2021,

4 (1).

[23]Chabuk S K, Hameed A K, Naser S a A, et al.The

Epidemiology and Pathophysiology of Breast Cancer[J].

International journal of health & medical research, 2024, 03 (09).

[24]Pavlova N P, Dyomin S S, Churnosov M I, et

al.Modern understanding of risk factors and mechanisms of

breast cancer development[J],2023.

[25]Singhal S, Singh M, Singh R K, et al.: Molecular

Mechanisms Underlying Breast Cancer and Role of Plant

Products in Targeted Therapy: Elsevier,2021: 295-351.

[26]Yousefnia S, Forootan F S, Forootan F S, et

al.Mechanistic Pathways of Malignancy in Breast Cancer Stem

Cells[J]. Frontiers in Oncology,2020, 10: 452-.

[27]Zarychta E, Ruszkowska-Ciastek B.Cooperation

between Angiogenesis, Vasculogenesis, Chemotaxis, and

Coagulation in Breast Cancer Metastases Development:

Pathophysiological Point of View[J].Advances in

Cardiovascular Diseases, 2022, 10 (2): 300-300.

[28]Zheng X, Dong W, Wang Y, et al.Research progress

in the pathogenesis of breast cancer mediated by breast and

intestinal flora[J].MEDS Clinical Medicine,2022, 3.

[29]Pu M, Tian K, Zheng W, et al.Sparse Modeling

of Genomic Landscape Identifies Pathogenic Processes and

Therapeutic Targets in Metastatic Breast Cancer[J].bioRxiv,

2023.

[30]Pu M, Tian K, Zheng W, et al.Unveiling Pathogenesis

and Therapeutic Targets of Metastatic Breast Cancer Through

Sparse Modeling of Genomic Landscape[J].Deleted Journal,

2024, 1: 100007-100007.

[31]王淑玉，宋玉，马运华.四种肿瘤标志物诊断乳

腺癌的价值探讨[J].山东医药，2012，52（07）：85-86.

[32]Sagiraju H K R, Gogia A, Sharma R, et

al.Association of pre-treatment hemoglobin levels with

survival outcomes among Indian women with triple negative

breast cancer[J].Journal of Clinical Oncology,2022, 40 (16_

suppl): e12549-e12549.

[33]Oh T K, Song I A.Anemia may increase the overall

risk of cancer: Findings from a cohort study with a 12-year

follow-up period in South Korea[J].Cancer Epidemiology,

Biomarkers & Prevention,2021, 30 (7): 1440-1448.

[34]Shilpa M D, Kalyani R, Sreeramulu P N.Prognostic

value of pre-treatment routine hematological parameters in

breast carcinoma: Advantageous or deleterious?[J].Biomedical

Research and Therapy,2020, 7 (8): 3916-3920.

[35]Sanagoo A, Kiani F, Gharenaz M S, et al.A

systematic review and meta-analysis on the association of

serum and tumor tissue iron and risk of breast cancer[J].

caspian journal of internal medicine,2020, 11 (1): 1-11.

[36]Blindar V N, Zubrikhina G N, Davydova T V,

et al.Peculiarities of iron metabolism in patients with breast

cancer before adjuvant chemotherapy[J],2022, 21 (1): 33-41.

[37]Jiang T, Sun H, Xue S, et al.Prognostic significance

of hemoglobin, albumin, lymphocyte, and platelet (HALP)

score in breast cancer: a propensity score-matching study[J].

Cancer Cell International,2024, 24 (1).

[38]Hua X, Duan F, Huang J J, et al.A Novel Prognostic

Model Based on the Serum Iron Level for Patients With

Early-Stage Triple-Negative Breast Cancer[J].Frontiers in

Cell and Developmental Biology,2021, 9: 777215-.

[39]Ayoub N M, Jaradat S K, Alhusban A, et

al.Glycosylated Hemoglobin A1c Is Associated with

Anthropometric Measurements and Tumor Characteristics in

Breast Cancer Patients[J].International Journal of Women’s

Health,2020, 12: 139-149.

[40]Wen C, Wu L-X, Fu L-J, et al.Unifying

mechanism in the initiation of breast cancer by metabolism of

estrogen (Review)[J].Molecular Medicine Reports,2017, 16

(2): 1001-1006.

[41]Liehr J, Jones J.Role of Iron in Estrogen-Induced

Cancer[J].Current Medicinal Chemistry,2001, 8 (7): 839-849.

[42]Lykkesfeldt A E, Laursen I, Briand P: The Role ofEstrogen Regulated Secreted Proteins for Growth Regulation

of Human Breast Cancer: Springer, Boston, MA,1992: 81-91.

[43]Fox J E, Liu H, Jordan V C: Estrogen Action and

Breast Cancer: Humana Press, Totowa, NJ,2000: 169-196.

[44]Jimoh M A, Arinola G O.Immune-nutritional

indices in female Nigerian breast cancer patients with different

tumour characteristics[J].Journal of basic and applied research,

2023, 9 (1): 5-8.

[45]Šrámek V, Melichar B, Študentová H, et al.Systemic

immune response and peripheral blood cell count in patients

with a history of breast cancer[J].Pteridines,2013, 24.

[46]Amens J N, Bahcecioglu G, Zorlutuna P.Immune

System Effects on Breast Cancer[J].Cellular and Molecular

Bioengineering, 2021, 14 (4): 279-292.

[47]Williams M M, Hafeez S A, Christenson J L, et

al.1445 Breast tumor cell heme metabolism alters macrophage

immune suppression and function to support lung

metastasis[J], 2023.

[48]Williams M A, Hafeez S A, Christenson J L, et al.

1423 Breast tumor cell heme metabolism alters macrophage

immune suppression and function to support lung metastasis[C],

2022.

[49]Kulinich G V, Kuzmenko O V, Sorochan P

P.Features of hematological and immune disorders in the

combined treatment of breast cancer patients with the risk

of development of late radiation damage[J].Ukraïnsʹkij

radìologìčnij ta onkologìčnij žurnal,2022, 30 (4): 39-51.

[50]Boehm D, Lebrecht A, Schmidt M, et al.Prognostic

Impact of Haemoglobin Levels in Breast Cancer[J].Anticancer

Research, 2007, 27 (2): 1223-1226.

[51]Huang X.Does iron have a role in breast cancer[J].

Lancet Oncology,2008, 9 (8): 803-807.

[52]Kabat G C, Rohan T E.Does excess iron play a role

in breast carcinogenesis? An unresolved hypothesis[J].Cancer

Causes & Control,2007, 18 (10): 1047-1053.

[53]Lin P-H, Yang H-J, Hsieh W-C, et al.Albumin

and hemoglobin adducts of estrogen quinone as biomarkers

for early detection of breast cancer[J].PLOS ONE,2018, 13 (9).


Refbacks

  • 当前没有refback。